The global Nucleic acid isolation and purification market is projected to reach USD 4.8 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 8.9% during the forecast period. The growth in this market is driven by increasing R&D activities, technological advancements, and increasing automation. However, the high cost of automated instruments is expected to hinder the growth of the market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=229978287
The nucleic acid isolation and purification market is well established owing to the dominance of prominent market players, such as QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), and Roche AG (Switzerland). Other prominent players in this market include Promega Corporation (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Danaher Corporation (US), GE Healthcare (US), Illumina, Inc. (US), Merck KGaA (Germany), Takara Bio (Japan), Zymo Research (US), New England Biolabs (US), Norgen Biotek Corp (Canada), Omega Bio-tek (US), Genaxxon Bioscience GmbH (Germany), 3B BlackBio Biotech India Limited (India), Invitek Molecular (Germany), BioVision (US), and Analytik Jena AG (Germany).
QIAGEN N.V. (Netherlands) was the largest player in the nucleic acid isolation and purification market in 2019. The dominant position of the company can be attributed to its strong brand image and robust product portfolio. The company focuses on organic and inorganic growth strategies to maintain its position in the market and expand its global presence. The company focuses on expansion in order to create a strong foothold in the market. In 2018, the company opened QIAGEN Business Services (QBS) Manila, its new shared service center, in the Philippines. This center will provide services related to supply chain management, customer care, accounting, technical services, and other sales support activities.
Get 10% Customization on this Research Report :- https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=229978287
Thermo Fisher Scientific (US) is the second-leading player in the global nucleic acid isolation and purification market. The company focuses on organic and inorganic growth strategies to maintain its position in the market and expand its global presence. For instance, the company announced the acquisition of QIAGEN N.V., a leading global provider of molecular diagnostics and sample preparation technologies. This acquisition is expected to expand the company’s specialty diagnostics portfolio with innovative sample preparation, assay, and bioinformatics technologies, in March 2020.
Browse Related Reports:
Isothermal Nucleic Acid Amplification Technology/INAAT Market by Product (Assay & Kit, System), Application (Infectious disease [HIV, Influenza], Blood Screening), Type (LAMP, SDA, NASBA, HDA), End User, Region - Global Forecast to 2024 https://www.marketsandmarkets.com/Market-Reports/isothermal-nucleic-acid-amplification-technologies-inaat-market-839.html
Genomics Market by Product & Service (System & Software, Consumables, Services), Technology (Sequencing, PCR), Application (Drug Discovery & Development, Diagnostic, Agriculture), End User (Hospital & Clinics, Research Centers) – Global Forecast to 2025 https://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html
Comments